In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.
The current state of metabolomics research and application in Acute Myeloid Leukaemia is placed under the spotlight by Bradley Stockard and Jatinder Lamba from Department of Pharmacotherapy and Translational Research, University of Florida
Anna Knuuttila, Senior Scientist and Kaisa Helminen, CEO of Fimmic explain how artificial intelligence (AI) empowers pathologists when it comes to cancer care.
Professor of Developmental Mechanics at the Department of Genetics, University of Cambridge, Alfonso Martinez Arias shares his expert view on Organoids, within the field of developmental biology.
Managing Director of The Cancer Drug Development Forum, Prof. H. Zwierzina reveals his opinions on the current and future challenges of personalised cancer therapy, including the need for biomarkers.
Ivan Stamenkovic, Professor of Experimental Pathology at University of Lausanne explores the paediatric sarcoma metastasis and why this warrants an in-depth look
Metastasis is responsible...
Prime Minister Theresa May has announced a further £75m in funding for “earlier and faster” diagnosis and treatment of prostate cancer, which kills more than 10,000 men each year
Europa Uomo – European Prostate Cancer Coalition Secretary, John Dowling shares his thoughts on the prostate gland, described as a most troublesome piece of tissue.
Researchers at the National Institutes of Health (NIH) have used genomics to set apart squamous cancer cells (SCC’s) from other cancers. This could improve treatments for head and neck cancers.
Bethany Torr, campaigns and advocacy officer at Leukaemia Care discusses the impact of chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML) on patients
New research has found that the Zika virus could be an alternative for treatment of glioblastoma, the most common and aggressive kind of brain cancer in adults
Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Acute myeloid...
Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government
Acute myeloid leukaemia (AML) is a form...
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography
The Murray and Nadel’s...
